S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
ACAD · ACADIA Pharmaceuticals Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
ACADIA Pharmaceuticals Inc (ACAD)
NASDAQ NMS - GLOBAL MARKET
Biotechnology
$20.20
-0.25
(-1.20%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$20.20
$20.11
$20.52
52-WEEK RANGE
$20.20
$18.39
$30.96
What's happening
- ACAD is down 1.20% today, trading at $20.20. — Live quote
- Volume today (132,354) is well below its 3-month average of 1,846,350. (Finnhub fundamentals)
- Reports earnings on 2026-11-11, 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.18 actual vs. $0.06 estimated (+207.2%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 7
Buy 13
Hold 5
Sell 1
Strong sell 0
Aggregate ratings for 2026-10-01 (26 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
ACAD
-24.41%
vs S&P 500
-37.78%
1-YEAR RETURN
ACAD
-5.08%
vs S&P 500
-20.24%
6-MONTH RETURN
ACAD
-8.93%
3-MONTH RETURN
ACAD
-19.11%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.18
Est. $0.06
BEAT +207.2%
2026-04-26 (Q1 2026)
$0.02
Est. $0.06
MISS -68.4%
2026-01-26 (Q4 2025)
$1.60
Est. $0.14
BEAT +1044.5%
2025-10-26 (Q3 2025)
$0.42
Est. $0.15
BEAT +178.1%
Valuation Measures & Ratios
Enterprise Value4$3.15B
Forward P/E531.65
PEG Ratio60.14
Price / Sales (TTM1)3.10
Price / Book73.32
EV4 / Revenue2.76
EV4 / EBITDA35.95
Profit Margin33.42%
Operating Margin7.59%
Return on Equity (ROE8)32.39%
Return on Assets (ROA9)24.38%
Avg Volume (3M)1,846,350
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $4.43B | $4.05B | $3.65B | $3.60B | $2.87B |
| P/E | 33.16 | 33.47 | 24.27 | 32.17 | 28.19 |
| Price/Sales | 3.96 | 3.84 | 3.51 | 3.59 | 3.04 |
| Price/Book | 3.39 | 3.25 | 3.97 | 4.37 | 3.75 |
| EV/Revenue | 3.61 | 3.57 | 3.26 | 3.34 | 2.81 |
| ROE | 10.22% | 9.70% | 16.37% | 13.60% | 13.29% |
| ROA | 7.66% | 7.54% | 11.29% | 9.12% | 8.98% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short8,275,918
Change from Prior Settlement-14.39%
% of Float—
Days to Cover (Short Ratio)2.93
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 16.4% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 33.4%. Finnhub fundamentals ↗
Potential concerns
- Trailing 52-week price return is -5.1%. Finnhub market metrics ↗
- Latest SEC filing is Form 8-K, filed 2026-09-24; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on ACAD
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $308.0M | $268.1M | $278.6M | $264.6M | $244.3M | $250.4M | $242.0M | $205.8M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $37.8M | -$4.6M | $35.8M | $32.4M | $19.3M | $31.6M | $30.4M | $15.2M |
| Net income | $31.5M | $3.6M | $71.8M | $26.7M | $19.0M | $32.8M | $33.4M | $16.6M |
| EPS (diluted) | $0.18 | $0.02 | $0.42 | $0.16 | $0.11 | $0.20 | $0.20 | $0.10 |
| EPS (basic) | $0.18 | $0.02 | $0.43 | $0.16 | $0.11 | $0.20 | $0.20 | $0.10 |
| Operating margin | $12 | -$2 | $13 | $12 | $8 | $13 | $13 | $7 |
| Net margin | $10 | $1 | $26 | $10 | $8 | $13 | $14 | $8 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $1.74B | $1.61B | $1.56B | $1.33B | $1.23B | $1.13B | $1.19B | $976.9M |
| Total liabilities | $436.3M | $357.2M | $336.8M | $413.5M | $403.2M | $367.1M | $455.0M | $399.7M |
| Stockholders' equity | $1.31B | $1.25B | $1.23B | $917.3M | $822.4M | $765.2M | $732.8M | $577.2M |
| Total current assets | $1.22B | $1.10B | $1.06B | $1.08B | $960.6M | $870.9M | $938.3M | $788.3M |
| Total current liabilities | $361.4M | $305.5M | $277.1M | $356.6M | $330.0M | $302.5M | $394.9M | $343.9M |
| Cash & equivalents | $385.0M | $282.2M | $177.7M | $258.0M | $253.6M | $217.7M | $319.6M | $155.1M |
| Accounts receivable | $150.6M | $135.3M | $121.5M | $115.8M | $107.5M | $105.7M | $98.7M | $98.2M |
| Inventory | $108.7M | $112.3M | $111.4M | $106.0M | $110.5M | $103.0M | $91.7M | $86.7M |
| Property, plant & equipment | $17.1M | $14.7M | $7.5M | $3.7M | $3.5M | $3.5M | $4.2M | $4.0M |
| Intangible assets | $103.4M | $106.2M | $108.9M | $111.6M | $114.3M | $117.1M | $119.8M | $105.5M |
| Other non-current assets | $3.5M | $3.9M | $3.9M | $3.0M | $2.3M | $1.5M | $359.0K | $359.0K |
| Accounts payable | $44.6M | $12.2M | $10.9M | $21.7M | $20.1M | $18.1M | $16.2M | $19.1M |
| Accrued liabilities | $316.9M | $293.3M | $266.2M | $334.8M | $309.9M | $284.4M | $378.7M | $324.9M |
| Deferred revenue (current) | — | — | — | — | — | — | — | — |
| Short-term debt | — | — | — | — | — | — | — | — |
| Other non-current liabilities | $15.3M | $12.6M | $19.1M | $13.9M | $28.5M | $20.0M | $18.1M | $15.3M |
| Common stock & paid-in capital | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K |
| Retained earnings | -$1.78B | -$1.81B | -$1.81B | -$2.09B | -$2.16B | -$2.19B | -$2.20B | -$2.35B |
| Accumulated other comprehensive income (loss) | -$958.0K | -$563.0K | $1.4M | $989.0K | $406.0K | $437.0K | $292.0K | $858.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $100.8M | $34.0M | -$48.7M | $74.3M | $64.0M | $20.3M | $40.4M | $63.2M |
| Investing cash flow | -$8.5M | $66.3M | -$55.9M | -$79.4M | -$43.3M | -$124.0M | $122.2M | -$82.5M |
| Financing cash flow | $10.5M | $4.2M | $22.7M | $9.4M | $16.0M | $1.8M | $2.0M | $268.0K |
| Free cash flow | $95.7M | $28.8M | -$52.7M | $73.9M | $63.7M | $20.3M | $39.9M | $63.2M |
| Capital expenditures | $5.1M | $5.2M | $4.0M | $388.0K | $297.0K | $0 | $453.0K | $70.0K |
| Share-based compensation | $16.9M | $14.7M | $13.2M | $13.2M | $14.3M | $11.4M | $10.4M | $26.2M |
| Deferred income taxes | — | — | -$250.3M | — | — | — | $0 | — |
| Change in accounts receivable | $15.3M | $13.9M | $5.6M | $8.3M | $1.8M | $7.0M | $530.0K | -$5.5M |
| Change in inventory | -$3.9M | -$78.0K | $4.9M | -$1.2M | $4.1M | $10.5M | $4.4M | $1.3M |
| Change in accounts payable | $32.3M | $1.3M | -$10.8M | $1.6M | $2.0M | $1.9M | -$2.9M | -$801.0K |
| Purchases of investments | $93.4M | $15.0M | $157.6M | $204.6M | $174.4M | $156.0M | $135.8M | $151.5M |
| Sales/maturities of investments | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $1.07B | $957.8M | $726.4M | $517.2M | $484.1M |
| Gross profit | — | — | $684.8M | $507.1M | $473.3M |
| Operating income | $104.8M | $230.8M | -$73.4M | -$223.6M | -$170.4M |
| Net income | $391.0M | $226.5M | -$61.3M | -$216.0M | -$167.9M |
| EPS (diluted) | $2.30 | $1.36 | $-0.37 | $-1.34 | $-1.05 |
| EPS (basic) | $2.32 | $1.37 | $-0.37 | $-1.34 | $-1.05 |
| Operating margin | $10 | $24 | -$10 | -$43 | -$35 |
| Net margin | $36 | $24 | -$8 | -$42 | -$35 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $1.56B | $1.19B | $749.0M | $587.8M | $700.1M |
| Total liabilities | $336.8M | $455.0M | $317.2M | $187.4M | $159.2M |
| Stockholders' equity | $1.23B | $732.8M | $431.8M | $400.4M | $540.9M |
| Total current assets | $1.06B | $938.3M | $616.1M | $507.9M | $617.8M |
| Total current liabilities | $277.1M | $394.9M | $254.3M | $125.6M | $96.1M |
| Cash & equivalents | $177.7M | $319.6M | $188.7M | $114.8M | $147.4M |
| Accounts receivable | $121.5M | $98.7M | $98.3M | $62.2M | $64.4M |
| Inventory | $111.4M | $91.7M | $40.4M | $11.6M | $14.1M |
| Property, plant & equipment | $7.5M | $4.2M | $4.6M | $6.0M | $8.0M |
| Intangible assets | $108.9M | $119.8M | $65.5M | $0 | — |
| Other non-current assets | $3.9M | $359.0K | $476.0K | $7.6M | $4.0M |
| Accounts payable | $10.9M | $16.2M | $17.5M | $12.7M | $6.9M |
| Accrued liabilities | $266.2M | $378.7M | $236.7M | $112.9M | $89.2M |
| Deferred revenue (current) | — | — | — | — | — |
| Short-term debt | — | — | — | — | — |
| Other non-current liabilities | $19.1M | $18.1M | $15.1M | $9.1M | $7.0M |
| Common stock & paid-in capital | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K |
| Retained earnings | -$1.81B | -$2.20B | -$2.43B | -$2.37B | -$2.15B |
| Accumulated other comprehensive income (loss) | $1.4M | $292.0K | $24.0K | -$975.0K | -$192.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $109.8M | $157.7M | $16.7M | -$114.0M | -$125.7M |
| Investing cash flow | -$302.6M | -$30.5M | $32.0M | $73.2M | -$71.1M |
| Financing cash flow | $49.9M | $6.8M | $25.1M | $8.2M | $18.2M |
| Free cash flow | $105.1M | $157.2M | $16.7M | -$114.0M | -$126.8M |
| Capital expenditures | $4.7M | $523.0K | $50.0K | $0 | $1.1M |
| Share-based compensation | $52.1M | $67.0M | $66.4M | $68.2M | $63.6M |
| Deferred income taxes | -$250.3M | $0 | $0 | $2.5M | $351.0K |
| Change in accounts receivable | $22.7M | $472.0K | $36.1M | -$2.2M | $16.1M |
| Change in inventory | $18.2M | $49.5M | $28.8M | -$2.4M | $4.2M |
| Change in accounts payable | -$5.3M | -$1.4M | $4.8M | $5.9M | -$1.6M |
| Purchases of investments | $692.6M | $505.1M | $370.0M | $363.2M | $492.8M |
| Debt repaid | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding ACAD as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 31 filers
Held by These Filers81.0%
Shares Outstanding171,603,000
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 42,912,904 | $1.09B | 25.01% | +0.0% | 2026-08-14 |
| BlackRock, Inc. | 22,515,173 | $569.6M | 13.12% | +4.5% | 2026-08-07 |
| State Street Corp | 9,076,212 | $229.6M | 5.29% | +8.9% | 2026-08-07 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 8,838,450 | $223.6M | 5.15% | +1.9% | 2026-06-30 |
| RTW INVESTMENTS, LP | 7,144,524 | $180.8M | 4.16% | +0.0% | 2026-08-14 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,763,750 | $145.8M | 3.36% | +1.8% | 2026-06-30 |
| DIMENSIONAL FUND ADVISORS LP | 3,694,988 | $93.5M | 2.15% | +17.1% | 2026-08-11 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,358,129 | $85.0M | 1.96% | -3.1% | 2026-08-12 |
| Goldman Sachs Group Inc | 2,580,115 | $65.3M | 1.50% | +65.6% | 2026-08-14 |
| Qube Research & Technologies Ltd | 2,446,610 | $61.9M | 1.43% | +157.5% | 2026-08-14 |
| Point72 Asset Management, L.P. | 2,433,168 | $61.6M | 1.42% | -5.6% | 2026-08-14 |
| CITADEL ADVISORS LLC | 2,182,177 | $55.2M | 1.27% | +250.4% | 2026-08-14 |
| Pictet Asset Management Holding SA | 1,983,198 | $50.1M | 1.16% | -2.1% | 2026-07-30 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1,969,445 | $49.8M | 1.15% | +25.5% | 2026-08-13 |
| MARSHALL WACE, LLP | 1,764,838 | $44.7M | 1.03% | +2216.5% | 2026-08-13 |
| D. E. Shaw & Co., Inc. | 1,697,937 | $43.0M | 0.99% | +132.6% | 2026-08-14 |
| BRAIDWELL LP | 1,646,399 | $41.7M | 0.96% | -33.4% | 2026-08-14 |
| NORGES BANK | 1,623,308 | $41.1M | 0.95% | +0.0% | 2026-08-12 |
| Frazier Life Sciences Management, L.P. | 1,438,198 | $36.4M | 0.84% | +0.0% | 2026-08-14 |
| Northern Trust Corp | 1,367,422 | $34.6M | 0.80% | +7.5% | 2026-08-12 |
| Nuveen, LLC | 1,348,192 | $34.1M | 0.79% | +30.0% | 2026-08-11 |
| Artisan Partners Limited Partnership | 1,325,134 | $33.5M | 0.77% | -0.5% | 2026-08-13 |
| Bank Of America Corp /De/ | 1,300,385 | $32.9M | 0.76% | -16.3% | 2026-08-14 |
| RENAISSANCE TECHNOLOGIES LLC | 1,282,596 | $32.4M | 0.75% | -25.6% | 2026-08-13 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,206,336 | $30.5M | 0.70% | +2.8% | 2026-08-14 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-03-24 to 2026-08-06
Recent transactions
- Insiders have net sold 58,359 shares over the last 182 days, across 0 purchases and 9 sales.
- Most recent: Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) — Option exercise of 14,292 shares on 2026-08-06.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)58,359 sh(9 txns)
Net Shares-58,359
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Option exercise | 2026-08-06 | 14,292 |
| Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | Open market sale | 2026-07-30 | 16,508 |
| Kihara James | PRINCIPAL ACCOUNTING OFFICER | Open market sale | 2026-06-26 | 11,421 |
| BAKER BROS. ADVISORS LP | Reporting person | Grant / award | 2026-05-29 | 18,622 |
| HARRIGAN EDMUND | Reporting person | Option exercise | 2026-05-29 | 8,107 |
| Ndu Adora | Reporting person | Option exercise | 2026-05-29 | 8,107 |
| Brege Laura | Reporting person | Option exercise | 2026-05-29 | 8,107 |
| Poole Jonathan | Reporting person | Option exercise | 2026-05-29 | 2,010 |
| GAROFALO ELIZABETH A. | Reporting person | Option exercise | 2026-05-29 | 8,107 |
| Daly James M | Reporting person | Option exercise | 2026-05-29 | 8,107 |
| Owen Adams Catherine | Chief Executive Officer | Open market sale | 2026-03-25 | 11,641 |
| Rhodes Jennifer J | EVP, CHIEF LEGAL OFFICER, SEC | Open market sale | 2026-03-25 | 3,844 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-06 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Option exercise | 14,292 | $17.84 |
| 2026-08-06 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Open market sale | 5,000 | $29.00 |
| 2026-08-06 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Open market sale | 9,292 | $29.34 |
| 2026-08-05 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Option exercise | 5,849 | $17.84 |
| 2026-08-05 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Open market sale | 5,849 | $29.00 |
| 2026-07-30 | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | Open market sale | 16,508 | $26.13 |
| 2026-07-30 | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | Open market sale | 50 | $26.17 |
| 2026-07-29 | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | Option exercise | 32,272 | — |
| 2026-06-26 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | Open market sale | 11,421 | $26.08 |
| 2026-05-29 | BAKER BROS. ADVISORS LP | Reporting person | Grant / award | 18,622 | $0.00 |
| 2026-05-29 | BAKER BROS. ADVISORS LP | Reporting person | Grant / award | 18,622 | $0.00 |
| 2026-05-29 | HARRIGAN EDMUND | Reporting person | Option exercise | 8,107 | — |
| 2026-05-29 | Ndu Adora | Reporting person | Option exercise | 8,107 | — |
| 2026-05-29 | Brege Laura | Reporting person | Option exercise | 8,107 | — |
| 2026-05-29 | Poole Jonathan | Reporting person | Option exercise | 2,010 | — |
| 2026-05-29 | GAROFALO ELIZABETH A. | Reporting person | Option exercise | 8,107 | — |
| 2026-05-29 | Daly James M | Reporting person | Option exercise | 8,107 | — |
| 2026-05-26 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | Open market sale | 5,401 | $21.18 |
| 2026-05-04 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | Open market sale | 1,332 | $21.79 |
| 2026-05-04 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Open market sale | 3,506 | $21.79 |
| 2026-05-01 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | Option exercise | 2,596 | — |
| 2026-05-01 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Option exercise | 6,815 | — |
| 2026-04-07 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Open market sale | 2,709 | $22.20 |
| 2026-04-07 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | Open market sale | 1,030 | $22.20 |
| 2026-04-05 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Option exercise | 5,276 | — |
| 2026-04-05 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | Option exercise | 2,010 | — |
| 2026-03-26 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | Open market sale | 1,097 | $21.65 |
| 2026-03-26 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | Open market sale | 12 | $21.73 |
| 2026-03-26 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Open market sale | 3,171 | $21.65 |
| 2026-03-26 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Open market sale | 37 | $21.72 |
| 2026-03-25 | Owen Adams Catherine | Chief Executive Officer | Open market sale | 11,641 | $21.47 |
| 2026-03-25 | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | Open market sale | 3,435 | $21.47 |
| 2026-03-25 | Rhodes Jennifer J | EVP, CHIEF LEGAL OFFICER, SEC | Open market sale | 3,844 | $21.47 |
| 2026-03-25 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | Open market sale | 833 | $21.47 |
| 2026-03-25 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | Option exercise | 2,142 | — |
| 2026-03-25 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Open market sale | 4,177 | $21.47 |
| 2026-03-25 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Option exercise | 6,178 | — |
| 2026-03-24 | Owen Adams Catherine | Chief Executive Officer | Option exercise | 23,509 | $0.00 |
| 2026-03-24 | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | Option exercise | 6,715 | — |
| 2026-03-24 | Rhodes Jennifer J | EVP, CHIEF LEGAL OFFICER, SEC | Option exercise | 7,515 | $0.00 |
| 2026-03-24 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | Option exercise | 1,627 | — |
| 2026-03-24 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Option exercise | 8,138 | — |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 06:46 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-24 | 8-K | 2026-09-24 | View on SEC.gov → |
| 2026-09-11 | 8-K | 2026-09-11 | View on SEC.gov → |
| 2026-08-07 | 4 | 2026-08-05 | View on SEC.gov → |
| 2026-08-05 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-04 | 8-K | 2026-08-04 | View on SEC.gov → |
| 2026-07-31 | 4 | 2026-07-29 | View on SEC.gov → |
| 2026-06-29 | 4 | 2026-06-26 | View on SEC.gov → |
| 2026-06-02 | 4 | 2026-05-29 | View on SEC.gov → |
| 2026-06-01 | 4 | 2026-05-29 | View on SEC.gov → |
| 2026-06-01 | 4 | 2026-05-29 | View on SEC.gov → |
| 2026-06-01 | 4 | 2026-05-29 | View on SEC.gov → |
| 2026-06-01 | 4 | 2026-05-29 | View on SEC.gov → |
Recent news
Headlines about ACAD (ACADIA Pharmaceuticals Inc.). Links open the publisher — we don’t host full articles.
-
AcadeMedia AB (publ) (ACAD) Proposes SEK 2.80 Dividend, Up To SEK 430M Share Redemption
TradingView · 2026-10-22 -
ACADIA Pharmaceuticals Inc. (ACAD) Stock Forecasts
Yahoo Finance · 2026-10-21 -
Acadia Pharmaceuticals Inc. (ACAD) stock price, news, quote and history
Yahoo Finance UK · 2026-10-21 -
Acadia Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 4, 2026
Yahoo · 2026-10-21 -
Will Auvelity Continue to Aid Axsome's Top-Line Growth in Q3?
Yahoo · 2026-10-21 -
ACAD Dec 2026 29.000 call (ACAD261218C00029000) stock price, news, quote and history
Yahoo Finance UK · 2026-10-21 -
ACAD Dec 2026 29.000 call (ACAD261218C00029000) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-21 -
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD
FinancialContent · 2026-10-20
No headlines in this category right now — try “All”.